Health
-
Why firm answers about Omicron’s impact could take weeks
The emergence of the Omicron variant of the coronavirus, with a suite of mutations that suggests it might be extra…
Read More » -
The Nagoya Protocol shouldn’t shield pathogen hoarding
This week, health officials from around the world will meet in Geneva — and virtually — to discuss plans for…
Read More » -
New data, analyses take some of the shine off Merck’s Covid pill
New data, in addition to analyses by scientists at the Food and Drug Administration, may take some of the shine…
Read More » -
What to know about the coronavirus variant identified in South Africa
Scientists in South Africa have identified a new coronavirus variant with a worrisome combination of mutations that experts fear could…
Read More » -
New research casts further doubt on a common procedure used with IVF
A common IVF procedure offered to patients with the promise of increasing their likelihood of successful pregnancy actually does not…
Read More » -
Women in biotech on how to break down barriers
Agnieszka Czechowicz remembers what the Magenta Therapeutics website looked like before the biotech startup went public: She, as a scientific…
Read More » -
The pandemic is deeply affecting many people with eating disorders
Many Americans are becoming accustomed to discussing how pandemic-related lockdowns and remote engagement have changed our lives. The conversations tend…
Read More » -
Next boy up: Kids continue to die on high school football fields
“The glamorization of football and war lends to misguided metaphors,” wrote sports reporter Jason Shoot in the Spokane, Washington, Spokesman-Review.…
Read More » -
4 food allergy immunotherapy companies to watch
More and more children are developing food allergies — and biotech companies are springing up to take advantage of the…
Read More » -
Jury finds pharmacy chains recklessly distributed opioids
Hello there, and happy pre-Turkey Day. STAT reporter Andrew Joseph here filling in for Mr. Pharmalot. We’re at a family…
Read More »
